For example, Takinami et al. [125] transfected F310L or F310L and V365I (F310L/V365I) in ALPL from HPP patients into COS-1 cells and observed a 67% and 31% reduction, respectively, in ALP activity compared with that in WT mice. This evidence concerns the gene ALPL and hypophosphatasia.